Agnirva Space Premier League - Expedition #30400: Unlocking Cancer Clues: Crystallizing RAS Proteins in Microgravity

RAS proteins play a key role in regulating cell division, and mutations in RAS genes are commonly linked to cancer. Understanding these proteins at a structural level is crucial for developing effective cancer therapies. However, RAS proteins are notoriously difficult to crystallize on Earth due to gravity-driven convection and sedimentation that disturb the crystallization process.

To overcome these challenges, scientists led by Dr. Dhirendra Simanshu from the Frederick National Laboratory for Cancer Research turned to space. Aboard the International Space Station (ISS), they conducted the “Crystallization of RAS in Space” experiment during Expeditions 57 and 58. In the microgravity environment of the ISS, RAS proteins could form crystals that are larger and more well-ordered than those grown on Earth.

Why does this matter? High-quality crystals are essential for X-ray crystallography, a method used to determine the 3D structure of proteins. With clearer structures, researchers can design drugs that target specific sites on the RAS protein more effectively. This precision could lead to the development of therapies that inhibit the cancer-causing function of mutated RAS proteins.

This space experiment is not just a leap in structural biology—it’s a leap toward new cancer treatments. The success of growing RAS crystals in microgravity could pave the way for similar studies on other challenging proteins.

Join the Agnirva Space Internship Program

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.